Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Mental Health Status and Related Factors Among Physical Medicine & Rehabilitation Physicians in the Covid-19 Pandemic

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04500652
Recruitment Status : Recruiting
First Posted : August 5, 2020
Last Update Posted : August 5, 2020
Sponsor:
Information provided by (Responsible Party):
Banu Dilek, Dokuz Eylul University

Brief Summary:
In December 2019, a highly infectious disease caused by a novel coronavirus (SARS-CoV-2) emerged in Wuhan, China. On March 11th 2020, the World Health Organization (WHO) declared COVID-19 a pandemic. Facing this critical situation, health care workers on the front line are at risk of developing psychological distress and other mental health symptoms. Physical medicine and rehabilitation (PM&R) physicians works both in specialty outpateint/inpatient clinic and pandemic outpatient/inpatient clinics during the outbreak. Accordingly, PM&R physicians are expected to be mentally affected by COVID-19 pandemic. In this study we aimed to evaluate mental health status of PM&R physicians and related factors during COVID-19 pandemic. This study is a cross-sectional survey which is conducted on an online platform. Demographic data, working conditions of PM&R physicians and factors that may be related to mental health status is questioned in the survey. The Depression, Anxiety and Stress Scale - 21 (DASS-21) is used to measure the emotional states of depression, anxiety and stress.The Insomnia Severity Index (ISI) is used to assess the severity of both nighttime and daytime components of insomnia.

Condition or disease
Anxiety Depression Insomnia Covid19 Coronavirus

Layout table for study information
Study Type : Observational
Estimated Enrollment : 310 participants
Observational Model: Other
Time Perspective: Cross-Sectional
Official Title: Evaluation of Mental Health Status and Related Factors Among Physical Medicine & Rehabilitation Physicians During the Covid-19 Pandemic
Actual Study Start Date : June 27, 2020
Estimated Primary Completion Date : August 30, 2020
Estimated Study Completion Date : October 1, 2020





Primary Outcome Measures :
  1. Depression, Anxiety and Stress Scales 21 Score [ Time Frame: 5 months ]
    The Depression, Anxiety and Stress Scale - 21 Items (DASS-21) is a set of three self-report scales designed to measure the emotional states of depression, anxiety and stress.

  2. Insomnia severity index score [ Time Frame: 5 months ]
    The Insomnia Severity Index (ISI) is a brief instrument that was designed to assess the severity of both nighttime and daytime components of insomnia.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   24 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Physical medicine and rehabilitation physicians in Turkey who worked during COVID-19 pandemic in specialty outpatient/inpatient clinic or pandemic outpatient/inpatient clinic.
Criteria

Inclusion Criteria:

  • Being a physical medicine and rehabilitation physician
  • Worked during COVID-19 pandemic in specialty outpatient/inpatient clinic or pandemic outpatient/inpatient clinic.

Exclusion Criteria:

  • Being a specialist in a branch other than physical medicine and rehabilitation

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04500652


Contacts
Layout table for location contacts
Contact: Banu Dilek +905052248340 banu.dilek@deu.edu.tr

Locations
Layout table for location information
Turkey
Dokuz Eylul University Recruiting
Izmir, Turkey, 35000
Contact: Banu Dilek    +905052248340    banu.dilek@deu.edu.tr   
Sponsors and Collaborators
Dokuz Eylul University
Layout table for additonal information
Responsible Party: Banu Dilek, Principal Investigator, Dokuz Eylul University
ClinicalTrials.gov Identifier: NCT04500652    
Other Study ID Numbers: PMRMentalcovid
First Posted: August 5, 2020    Key Record Dates
Last Update Posted: August 5, 2020
Last Verified: August 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Banu Dilek, Dokuz Eylul University:
depression
anxiety
insomnia
Covid-19
coronavirus
Additional relevant MeSH terms:
Layout table for MeSH terms
Coronavirus Infections
Sleep Initiation and Maintenance Disorders
Depression
Behavioral Symptoms
Mental Disorders
Sleep Disorders, Intrinsic
Dyssomnias
Sleep Wake Disorders
Nervous System Diseases
Coronaviridae Infections
Nidovirales Infections
RNA Virus Infections
Virus Diseases